tirzepatide for cardiovascular disease In patients with type 2 diabetes and atherosclerotic disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://nej.md/4qd5rLx Obesity and heart failure: what

Managing nausea specifically: take injections at a time that minimises disruption to your daily routine, remain upright after meals, try ginger-based remedies, and avoid strong food odours during symptomatic periods

These patients were being treated with metformin with or without an SGLT2 inhibitor

However, in terms of weight loss, Mounjaro (Tirzepatide) has shown more significant results in clinical trials compared to Ozempic

A comprehensive data management plan, including eCRF, is implemented to ensure data security and storage

Reconstituted solution Once you add bacteriostatic water to a 10mg vial, the clock starts ticking

By the end of 2022, Mounjaro had sales of $482.5 million